This country profile provides an overview of Mauritania’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profiles

Treatment coverage

Elephantiasis
N/A
Blinding trachoma
0%
Intestinal worms
N/A
Bilharzia
82%
River blindness
N/A
0.27 million people received treatment in Mauritania in 2017 0.58 million people did not receive treatment in Mauritania in 2017

Priorities for progress in Mauritania

  • Mauritania is encouraged to maintain the high levels of coverage for bilharzia in school age children.
  • For trachoma, it should conduct surveys in Hodh El Charghui (Nema, Timbedra, Basseknou, Amourj, and Oualata) in 2019 to establish the endemicity status and decide whether there is need for interventions or not. This would help complete the mapping of trachoma for the country, in preparation of a potential elimination dossier.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Mauritania does not require mass treatment for elephantiasis.

Blinding trachoma

Treatment coverage was 0% in 2016 and 2017.

People needing treatment
0.34m
People receiving treatment
0m

Intestinal worms

Mauritania does not require mass treatment for intestinal worms.

Bilharzia

Treatment coverage increased from 0% in 2016 to 82% in 2017.

School-aged children needing treatment
0.33m
School-aged children receiving treatment
0.27m

River blindness

Mauritania does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Mauritania.